Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Research Reports > Companion Animal Drugs Market to Gain Impetus from the Rise of Compounded Medications

Research Reports

Companion Animal Drugs Market to Gain Impetus from the Rise of Compounded Medications

Published by linker 5

Posted on February 12, 2021

3 min read

Last updated: January 21, 2026

Infographic illustrating NGS Sample Preparation Market analysis and trends - Global Banking & Finance Review — This image showcases an infographic summarizing key segments and benefits of the NGS Sample Preparation Market, highlighting statistical insights and forecasts for 2021 to 2027.

The companion animal drugs market is anticipated to grow at a CAGR of ~ 5% during the forecast period of 2019-2029. Growing affluence and rising urbanization level, particularly in developing nations, have been fueling pet adoption, thus directing towards an increased requirement for healthcare products for pets such as companion animal drugs. Incessant urbanization has additionally ensued in the growing occurrence of several ailments, for instance, lower appetite, allergies, behavioral anxieties and reduced energy amid small companion animals. This has been boosting the requirement for medicines innovative classes such as companion animal drugs

Increasing Urbanization and Growing Affluence in Developing Countries to Benefit the Market

Increasing urbanization level and growing affluence, especially in developing countries, have been driving the adoption of pets, thus leading to increased demand for healthcare products for pets such as companion animal drugs. Continued urbanization has also resulted in increasing prevalence of various diseases such as allergies, lower appetite, reduced energy and behavioral anxieties among small companion animals. This has been driving the demand for innovative classes of medicines such as companion animal drugs.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1077

A recent market study published by Future Market Insights on the companion animal drugs market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the companion animal drugs market, the growth prospects of the market are obtained with maximum precision.

Companion Animal Drugs Market: Segmentation

The global companion animal drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

Antibiotics
Anti-inflammatory
Parasiticides
Heart Worm Products
Behavioral Products
Nutritional Products
Skin Care Products
Vaccines

Distribution channel

Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores

Region

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East and Africa

Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-1077

Key Factors Shaping the Companion Animal Drugs Market

Increasing Rate of Pet Obesity
Emergence of New Technologies, Especially in Biologics
Growing Prominence of Online Veterinary Pharmacies

Key players operating in the global companion animal specialty drugs market are Zoetis, Inc., Merck & Co., Inc., Bayer AG, Elanco (a division of Eli Lilly & Company), Boehringer Ingelheim Animal Health Gmbh, Ceva Sante Animale S.A., Aratana therapeutics, Merial (acquired by Boehringer Ingelheim), The J.M Smucker Company, Mars, and Beaphar.

Insights Covered in the Global Companion Animal Drugs Market Research Report:

Research report offers the impact analysis of COVID-19 pandemic on the global Companion Animal Drugs Market.
Information covering each region & countries will be listed, in order to categorize the issues caused by the corona virus disease on the industry.
Market sizing &forecasting and Y-o-Y growth rate estimation of different segments and sub-segments of the market.
Assessment of the global market and its valuations regarding the market growth at each level (Global, Region & Country) are included.
Market dynamics section offering leading growth factors, challenges, industry trends and opportunities for upcoming & prominent players in the market.
Providing detailed analysis of recent government policies & funding on new growth avenues in order to tackle the market barriers & threats.
Enlisting the strategies adopted by the major & leading market players in order to analyze how these strategies will help them to grow.